Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4682-4686

  Zhuang, Zhengping ^a   Vortmeyer, Alexander O ^a   Pack, Svetlana ^a   Huang, Steve ^a   Pham, Thu A ^a   Wang, Chaoyu ^a   Park, Won Sang ^a   Agarwal, Sunita K ^b   Debelenko, Larisa V ^a   Kester, MaryBeth ^b   Guru, Siradanahalli C ^c   Manickam, Pachiappan ^c   Olufemi, Shodimu Emmanuel ^c   Yu, Fang ^b   Heppner, Christina ^b   Crabtree, Judy S ^c   Skarulis, Monica C ^b   Venzon, David J ^a   Emmert Buck, Michael R ^a   Spiegel, Allen M ^b   Chandrasekharappa, Settara C ^c   Collins, Francis S ^c   Burns, A Lee ^b   Marx, Stephen J ^b   Jensen, Robert T ^b   Liotta, Lance A ^a   Lubensky, Irina A ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GASTRINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; INSULINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GASTRINOMA; GENE DELETION; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INSULINOMA; JEJUNAL NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PANCREATIC NEOPLASMS;

EID: 0030810185     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jensen, R. T., and Norton, J. A. Endocrine tumors of the pancreas. In: T. Yamada, B. H. Alpers, C. Owyang, D. W. Powell, and F. E. Silverstein (eds.). Textbook of Gastroenterology, Ed. 2, pp. 2131-2166. Philadelphia: J. B. Lippincott Co., 1995.
2. Padberg, B., Schröder, S., Capella, C., Frilling, A., Klöppel, G., and Heitz, P. H. Multiple endocrine neoplasia type 1 (MEN1) revisited. Virchows Arch., 426: 541-548, 1995.
3. Debelenko, L. V., Zhuang, Z., Emmert-Buck, M. R., Settara C. Chandrasekharappa, S. C., Manickam, P., Guru, S. C., Marx, S. J., Skarulis, M. C., Spiegel, A. M., Collins, F. S., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Allelic deletions on chromosome 11q13 in MEN1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res., 57: 2238-2243, 1997.
4. Weber, H. S. and Jensen, R. T. Pancreatic endocrine tumors and carcinoid tumors: recent insights from genetic and molecular biologic studies. In: C. G. Dervenis (ed.). Advances in Pancreatic Disease: Molecular Biology, Diagnosis and Treatment, pp. 55-75. Stuttgart, Germany: Georg Thieme Verlag, 1996.
5. Knudson, A. G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
6. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. Multiple endocrine neoplasia type I maps to chromosome 11 and is lost in insulinoma. Nature (Lond.), 332: 85-87, 1988.
7. Emmert-Buck, M. R. Lubensky, I. A., Dong, Q., Manickam, P., Guru, S., Kester, M. B., Olufemi, S-E., Agarwal, S., Burns, A. L., Spiegel, A. M., Collins, F. S., Marx, S. J., Zhuang, Z., Liotta, L. A., Chandrasekharappa, S., and Debelenko, L. V. Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumor LOH analysis. Cancer Res., 57: 1855-1858, 1997.
8. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Washington DC), 276: 404-407, 1997.
9. Aaarwal, S., Kester, M. B., Debelenko, L. V., Heppner, C., Emmert-Buck, M. R., Skarulis, M., Doppman, J., Kim, Y., Lubensky, I. A., Zhuang, Z., Boguski, M. S., Weisemann, J., Green, J., Guru, S., Manickam, P., Olufemi, S-E., Liotta, L. A., Chandrasekharappa, S., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. Germline mutations of the MEN1 gene in familial MEN1 and related states. Hum. Mol. Genet., 6: 1169-1175, 1997.
10. Gorden, P., Skarulis, M. C., Roach, P., Comi, R. J., Fraker, D. L., Norton, J. A., Alexander, H. R., and Doppman, J. L. Plasma proinsulin-like component in insulinoma: a 25 year experience. J. Clin. Endocrinol. Metab., 80: 2884-2887, 1995.
11. Fishbeyn, V. A, Norton, J. A, Benya, R. V, Pisegna, J. R., Venzon, D. J., Metz, D. C., and Jensen, R. T. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. Ann. Intern. Med., 119: 199-206, 1993.
12. Benya, R. V., Metz, D. C., Venzon, D. J., Fishbeyn, V. A., Strader, D. B., Orbuch, M., and Jensen, R. T. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am. J. Med., 97: 436-444, 1994.
13. Lubensky, I. A., Debelenko, L. V., Zhuang, Z., Emmert-Buck, M. R., Dong, Q., Chandrasekharappa, S., Guru, S., Manickam, P., Olufemi, E-S., Marx, S. J., Spiegel, A., Collins, F. S., and Liotta, L. A. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res., 56: 5272-5278, 1996.
14. Orita, M., Iwahara H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
15. Guru, S., Olufemi, S-E., Manickam, P., Cummings, C., Gieser, L. M., Pike, B. L., Bittner, M. L., Jiang, Y., Chinault, A. S., Novack, N. J., Brozowska, A., Crabtree, J., Wang, Y., Roe, B., Weisemann, J., Boguski, M., Agarwal, S., Burns, A. L., Spiegel, A. M., Marx, S. J., Flejter, W. L., de Jong, P. J., Collins, F. S., and Chandrasekharappa, S. A 2.8 Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13. Genomics, 42: 436-445, 1997.
16. Pinkel, D., Straune, T., and Gray, J. W. Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc. Natl. Acad. Sci. USA, 83: 2934-2938, 1986.
17. Ried, T., Lengauer, C., Lipp, M., Fischer, C., Cremer, T., and Ward, D. C. Evaluation of the utility of interphase cytogenetics to detect residual cells with a malignant genotype in mixed cell populations: a Burkitt lymphoma model. DNA Cell Biol., 12: 637-643, 1993.
18. James, M. R., Richard, C. W., III, Schott. J-J., Yousry, C., Clark, K., Bell, J., Terwilliger, J. D., Hazan, J., Dubay, C., Vignal, A., Agrapart, M., Imai, T., Nakamura, Y., Polymeropoulos, M., Weissenbach, J., Cox, D. R., and Lathrop, G. M. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nat. Genet., 8: 70-76, 1994.
19. Manickam, P., Guru, S., Debelenko, L. V., Agarwal, S., Olufemi, S-E., Weisemann, J., Boguski, M., Crabtree, J., Roe, B., Wang, Y., Lubensky, I. A., Zhuang, Z., Kester, M. B., Burns, A. L., Spiegel, A. M., Marx, S. J., Liotta, L. A., Emmert-Buck, M. R., Collins, F. S., and Chandrasekharappa, S. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum. Genet., 101: 102-108, 1997.
20. Gnarra, J., Tory, K., Weng, Y., Schmidt, L., Wei, M., Li, H., Latif, F., Liu, S., Chen, F., Duh, F., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
21. Shepherd, J. J. The natural history of multiple endocrine neoplasia type I: highly uncommon or highly unrecognized. Arch. Surg., 126: 935-952, 1991.
22. Chung, D. C., Smith, A. P., Louis, D. N., Graeme-Cooke, F., Warshaw, A. L., and Arnold, A. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J. Clin. Invest., 100: 404-410, 1997.
23. Heppner, C., Kester, M. B., Agarwal, S., Debelenko, L. V., Emmert-Buck, M. R., Guru, S., Manickam, P., Olufemi, S-E., Skarulis, M., Doppman, J., Alexander, R., Kim, Y., Saggar, S., Lubensky, I. A., Zhuang, Z., Boguski, M., Weisemann, J., Liotta, L. A., Chandrasekharappa, S., Collins, F. S., Spiegel, A. M., Burns, A. L. and Marx, S. J. Somatic mutation of the MEN1 gene in sporadic parathyroid tumors. Nat. Genet., 16: 375-378, 1997.
24. Sheffield, V. C., Beck, J. S, Kwitek, A. E. Sandstrom, D. W., and Stone, E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics, 16: 325-332, 1993.
25. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
26. Herman, J. G, Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
27. Beaudet, A. L., and Tsui, L. A suggested nomenclature for designating mutations. Hum. Mutat., 2: 245-248, 1993.